Skip to Main Content

Paper Details

Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models.
bioRxiv
4
2020
COVID-19, SARS, SARS-, SARS-CoV-, SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, TPT, Top1, Topoisomerase 1, Topotecan, humans, inflammation, mouse

Datasets

Release 1.2